Publications

• Maternal Microchimerism, a Red Flag or a Red Herring in Very-Early-Onset Inflammatory Bowel Disease?
  Inflamm Bowel Dis Volume: 31 Page(s): 1748 - 1749
  06/13/2025 Authors: Munasinghe S; Chandrakasan S
• Expert-Based, Institutional Approaches for Reducing the Diagnostic Odyssey of Patients With Inborn Errors of Immunity.
  J Allergy Clin Immunol Pract Volume: 13 Page(s): 1317 - 1324
  06/01/2025 Authors: Rider NL; Bastarache L; Anderson JT; Behrens EM; Chaimowitz N; Chandrakasan S; Hartline B; Liu A; Marsh RA; Connelly JA
• Breaking the cycle: PRMTs and secondary HLH relief.
  Blood Adv Volume: 9 Page(s): 2436 - 2437
  05/27/2025 Authors: Malik S; Chandrakasan S
• Biomarkers of Immune Dysregulation and What They Tell Us: Gene Sequencing Is Not the Answer to Every Question.
  Immunol Allergy Clin North Am Volume: 45 Page(s): 173 - 188
  05/01/2025 Authors: Nguyen TH; Chandrakasan S
• Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH).
  Orphanet J Rare Dis Volume: 20 Page(s): 200
  04/26/2025 Authors: Naymagon L; Roehrs P; Hermiston M; Connelly J; Bednarski J; Boelens J-J; Chandrakasan S; Dvila Saldaa B; Henry MM; Satwani P
• Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.
  Blood Adv Volume: 9 Page(s): 1952 - 1965
  04/22/2025 Authors: Pierson SK; Brandstadter JD; Torigian DA; Bagg A; Lechowicz MJ; Alapat D; Casper C; Chadburn A; Chandrakasan S; Dispenzieri A
• Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study.
  Lancet Rheumatol Volume: 7 Page(s): e243 - e251
  04/01/2025 Authors: Matt MG; Drozdov D; Bendstrup E; Glerup M; Hauge E-M; Masmas T; Schneider EC; Zeilhofer UB; Abu-Arja RF; Driest KD
• Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.
  Arthritis Rheumatol Volume: 77 Page(s): 226 - 238
  02/01/2025 Authors: Chandrakasan S; Allen CE; Bhatla D; Carter J; Chien M; Cooper R; Draper L; Eckstein OS; Hanna R; Hays JA
• Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation.
  Front Immunol Volume: 16 Page(s): 1519955
  01/01/2025 Authors: Henderson LA; Abraham RS; Ahmed A; Blount L; Canna SW; Chaimowitz NS; Chandrakasan S; Coates B; Connelly JA; Cooper MA
• Systemic T-cell activation and IFN- activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell- and IFN--directed therapies.
  J Allergy Clin Immunol Volume: 155 Page(s): 199 - 212
  01/01/2025 Authors: Nguyen TH; Satwani P; Kumar D; Kapoor U; Malik S; Prince C; Montminy T; Smiley K; Martinez M; Goldner D
• Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project.
  Rheumatology (Oxford) Volume: 64 Page(s): 32 - 44
  01/01/2025 Authors: Baldo F; Erkens RGA; Mizuta M; Rogani G; Lucioni F; Bracaglia C; Foell D; Gattorno M; Jelusic M; Anton J
• Expanding the Spectrum of Immune Abnormalities in VICI Syndrome.
  J Clin Immunol Volume: 45 Page(s): 44
  11/18/2024 Authors: Frost EL; Youngblood LL; Hammers Y; Fitch T; Pencheva B; Chandrakasan S
• Pediatric lymphoproliferative disorders associated with inborn errors of immunity.
  Clin Immunol Volume: 266 Page(s): 110332
  09/01/2024 Authors: Cheng J; Dvila Saldaa BJ; Chandrakasan S; Keller M
• Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia.
  Res Sq
  08/02/2024 Authors: Zheng H; Zhao P; Tan Z; Yu W-M; Werner J; Stieglitz E; Porter C; Chandrakasan S; Wechsler D; Mendez-Ferrer S
• HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum.
  J Clin Immunol Volume: 44 Page(s): 153
  06/19/2024 Authors: Golloshi K; Mitchell W; Kumar D; Malik S; Parikh S; Aljudi AA; Castellino SM; Chandrakasan S
• Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.
  Blood Adv Volume: 8 Page(s): 2248 - 2258
  05/14/2024 Authors: Chandrakasan S; Jordan MB; Baker A; Behrens EM; Bhatla D; Chien M; Eckstein OS; Henry MM; Hermiston ML; Hinson AP
• Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: APrimary Immune Deficiency Treatment Consortium study.
  J Allergy Clin Immunol Volume: 153 Page(s): 1423 - 1431.e2
  05/01/2024 Authors: Grunebaum E; Arnold DE; Logan B; Parikh S; Marsh RA; Griffith LM; Mallhi K; Chellapandian D; Lim SS; Deal CL
• Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
  Nat Commun Volume: 15 Page(s): 3258
  04/18/2024 Authors: Keller MD; Hanley PJ; Chi Y-Y; Aguayo-Hiraldo P; Dvorak CC; Verneris MR; Kohn DB; Pai S-Y; Dvila Saldaa BJ; Hanisch B
• Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.
  Clin Immunol Volume: 261 Page(s): 109942
  04/01/2024 Authors: Abraham RS; Basu A; Heimall JR; Dunn E; Yip A; Kapadia M; Kapoor N; Satter LF; Buckley R; O'Reilly R
• Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.
  Nat Commun Volume: 15 Page(s): 2749
  03/29/2024 Authors: Keller MD; Schattgen SA; Chandrakasan S; Allen EK; Jensen-Wachspress MA; Lazarski CA; Qayed M; Lang H; Hanley PJ; Tanna J
• D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
  Am J Hematol Volume: 99 Page(s): 370 - 379
  03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B
• Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
  Transplant Cell Ther Volume: 30 Page(s): 336.e1 - 336.e8
  03/01/2024 Authors: Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J
• Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe.
  Pediatr Rheumatol Online J Volume: 21 Page(s): 86
  01/05/2024 Authors: Grom AA; Canna SW; Abu-Arja RF; Sinha R; Peixoto L; Cannizzaro E; Chandrakasan S; Driest K; Marsh R; Neven B
• Frequency of HLA-DR+CD38hi T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders.
  J Allergy Clin Immunol Volume: 153 Page(s): 309 - 319
  01/01/2024 Authors: Nguyen TH; Kumar D; Prince C; Martini D; Grunwell JR; Lawrence T; Whitely T; Chappelle K; Chonat S; Prahalad S
• JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
  J Allergy Clin Immunol Volume: 153 Page(s): 275 - 286.e18
  01/01/2024 Authors: Fischer M; Olbrich P; Hadjadj J; Aumann V; Bakhtiar S; Barlogis V; von Bismarck P; Bloomfield M; Booth C; Buddingh EP
• Posttransplantation late complications increase over time for patients with SCID: APrimary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
  J Allergy Clin Immunol Volume: 153 Page(s): 287 - 296
  01/01/2024 Authors: Eissa H; Thakar MS; Shah AJ; Logan BR; Griffith LM; Dong H; Parrott RE; O'Reilly RJ; Dara J; Kapoor N
• Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
  Blood Volume: 142 Page(s): 2105 - 2118
  12/14/2023 Authors: Leiding JW; Arnold DE; Parikh S; Logan B; Marsh RA; Griffith LM; Wu R; Kidd S; Mallhi K; Chellapandian D
• Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis.
  Volume: 142 Page(s): 1972 - 1984
  12/07/2023 Authors: Shim J; Park S; Venkateswaran S; Kumar D; Prince C; Parihar V; Maples L; Waller EK; Kugathasan S; Briones M
• Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
  12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
• Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
  Lancet Volume: 402 Page(s): 129 - 140
  07/08/2023 Authors: Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai S-Y
• IMPACT OF TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY AND ACUTE GRAFT VERSUS HOST DISEASE ON SURVIVAL IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC CELLULAR TRANSPLANTATION
  Volume: 70 Page(s): S217 - S217
  06/01/2023 Authors: Schoettler M; Harris A; Bryson E; Deeb L; Watkins B; Haight A; Parikh S; Chandrakasan S; Stenger E; Liang W
• DARATUMUMAB FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC PATIENTS POST-HEMATOPOIETIC CELL TRANSPLANT
  Volume: 70 Page(s): S214 - S215
  06/01/2023 Authors: Yoo J; Obordo J; Schoettler M; Qayed M; Hughes K; Harris A; Spencer K; Parikh S; Chandrakasan S; Chonat S
• EMAPALUMAB TREATMENT PATTERNS/OUTCOMES IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: REAL-HLH STUDY
  Volume: 70 Page(s): S62 - S62
  06/01/2023 Authors: Allen C; Chandrakasan S; Jordan M; Leiding J; Oladapo A; Pednekar P; Walkovich K; Yee J
• BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
  J Immunother Cancer Volume: 11
  05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
  J Allergy Clin Immunol Volume: 151 Page(s): 1081 - 1095
  04/01/2023 Authors: Leiding JW; Vogel TP; Santarlas VGJ; Mhaskar R; Smith MR; Carisey A; Vargas-Hernndez A; Silva-Carmona M; Heeg M; Rensing-Ehl A
• Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing.
  Pediatr Rheumatol Online J Volume: 21 Page(s): 17
  02/15/2023 Authors: Imbach KJ; Treadway NJ; Prahalad V; Kosters A; Arafat D; Duan M; Gergely T; Ponder LA; Chandrakasan S; Ghosn EEB
• The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
  J Allergy Clin Immunol Volume: 151 Page(s): 547 - 555.e5
  02/01/2023 Authors: Dvorak CC; Haddad E; Heimall J; Dunn E; Cowan MJ; Pai S-Y; Kapoor N; Satter LF; Buckley RH; O'Reilly RJ
• mTOR inhibition attenuates cTfh cell dysregulation and chronic T-cell activation in multilineage immune cytopenias.
  Blood Volume: 141 Page(s): 238 - 243
  01/19/2023 Authors: Kumar D; Nguyen TH; Bennett CM; Prince C; Lucas L; Park S; Lawrence T; Chappelle K; Ishaq M; Waller EK
• Editorial: NK cell defects: diagnosis and treatment.
  Front Immunol Volume: 14 Page(s): 1323793
  01/01/2023 Authors: Shabrish S; Chandrakasan S; Madkaikar M
• Ligand-based targeting of c-kit using engineered T cells as a strategy for treating acute myeloid leukemia.
  Front Immunol Volume: 14 Page(s): 1294555
  01/01/2023 Authors: Branella GM; Lee JY; Okalova J; Parwani KK; Alexander JS; Arthuzo RF; Fedanov A; Yu B; McCarty D; Brown HC
• Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase IV Syndrome.
  J Pediatr Hematol Oncol Volume: 45 Page(s): e139 - e141
  01/01/2023 Authors: Fridlyand DM; Chandrakasan S; Aljudi A; Aumann WK; Westfall E; Kirwan B; Bryson EW; Keller FG; Arnold SD; Hong AL
• Editorial: Dermatologic manifestations of primary immune deficiency disorders in children.
  Front Pediatr Volume: 11 Page(s): 1182474
  01/01/2023 Authors: Shamriz O; Chandrakasan S
• Clinical Determinants of Childhood Onset Systemic Lupus Erythematosus among Early and Peri-Adolescent Age Groups.
  Children (Basel) Volume: 9
  11/30/2022 Authors: Nelson MC; Chandrakasan S; Ponder L; Sanz I; Goldberg B; Ogbu EA; Rouster-Stevens K; Prahalad S
• AN ATYPICAL PRESENTATION OF FAMILIAL MEDITERRANEAN FEVER
  Volume: 129 Page(s): S126 - S127
  11/01/2022 Authors: Xu J; Chandrakasan S; Lee G
• GENETICALLY CONFIRMED TYPE I LEUKOCYTE ADHESION DEFICIENCY IN A TWO-YEAR-OLD MALE
  Volume: 129 Page(s): S137 - S137
  11/01/2022 Authors: Edwards-Salmon S; Chandrakasan S; Vickery B
• Compassionate use narsoplimab to treat transplant associated thrombotic microangiopathy in a pediatric patient with multi-organ failure
  Volume: 57 Page(s): 350 - 350
  11/01/2022 Authors: Schoettler M; Bryson E; Deeb L; Qayed M; Watkins B; Chandrakasan S; Chonat S; Williams K
• Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
  Nat Commun Volume: 13 Page(s): 6418
  10/27/2022 Authors: Ravindranathan S; Passang T; Li J-M; Wang S; Dhamsania R; Ware MB; Zaidi MY; Zhu J; Cardenas M; Liu Y
• CHILDREN WITH ACUTE SEVERE HEPATITIS OF UNDETERMINED ETIOLOGY HAVE A SYSTEMIC T CELL ACTIVATION AND INTERFERON GAMMA (IFN-G) ACTIVITY REMINISCENT OF HEMOPHAGOCYTIC HISTIOCYTOSIS: A POTENTIAL ROLE FOR T CELL AND IFN-G DIRECTED THERAPIES
  Volume: 76 Page(s): S1555 - S1555
  10/01/2022 Authors: Nguyen TH; Satwani P; Kumar D; Prince C; Remotti H; Goldner D; Vittorio JM; Romero R; Chandrakasan S
• Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
  Blood Volume: 140 Page(s): 685 - 705
  08/18/2022 Authors: Cuvelier GDE; Logan BR; Prockop SE; Buckley RH; Kuo CY; Griffith LM; Liu X; Yip A; Hershfield MS; Ayoub PG
• HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh.
  Blood Adv Volume: 6 Page(s): 3751 - 3755
  06/28/2022 Authors: Chandrakasan S; Chandra S; Prince C; Kobrynski LJ; Lucas L; Patel K; Walter J; Buckley RH; Meisel R; Ghosh S
• Targeted RNAseq Improves Clinical Diagnosis of Very Early-Onset Pediatric Immune Dysregulation.
  J Pers Med Volume: 12
  06/01/2022 Authors: Berger K; Arafat D; Chandrakasan S; Snapper SB; Gibson G
• BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Pauly M; Blum W; Qayed M; Dhodapkar M; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• REDUCING DURATION OF EMPIRIC ANTIBIOTICS IN CHILDREN UNDERGOING STEM CELL TRANSPLANTATION
  Volume: 69
  06/01/2022 Authors: Patel P; Teherani M; Xiang Y; Bernardo V; Chandrakasan S; Goggin K; Haight A; Horwitz E; Liang W; Parikh S
• Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
  JAMA Pediatr Volume: 176 Page(s): 576 - 584
  06/01/2022 Authors: Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W
• Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
  Blood Adv Volume: 6 Page(s): 3058 - 3061
  05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
• Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH).
  J Allergy Clin Immunol Volume: 149 Page(s): 1592 - 1606.e16
  05/01/2022 Authors: Kumar D; Rostad CA; Jaggi P; Villacis Nunez DS; Prince C; Lu A; Hussaini L; Nguyen TH; Malik S; Ponder LA
• Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells.
  Gene Ther Volume: 29 Page(s): 1 - 12
  05/01/2022 Authors: Zoine JT; Prince C; Story JY; Branella GM; Lytle AM; Fedanov A; Alexander JS; Porter CC; Doering CB; Spencer HT
• Sirolimus treatment improves both cytopenia and underlying immune dysregulation in Evans syndrome
  Volume: 42 Page(s): S100 - S101
  04/01/2022 Authors: KUMAR DEEPAK; Nguyen TH; Bennett CM; Lucas L; Prince C; Parikh S; Park S; Prahalad S; Briones M; Chandrakasan S
• Transplanted CGD Patients have Higher Burden of Disease than Conventionally Treated Patients that Resolve with Transplantation - A PIDTC Report
  Volume: 42 Page(s): S76 - S78
  04/01/2022 Authors: Leiding J; Danielle A; Parikh S; Logan B; Marsh R; Griffith L; Wu R; Mallhi K; Chellapandian D; Lim S
• B-cell driven autoimmunity in patients with genetically defined autoinflammatory disorders
  Volume: 149 Page(s): AB197 - AB197
  02/01/2022 Authors: Nguyen T; Kumar D; Prince C; Youngblood L; Chandrakasan S
• Therapeutic options for CTLA-4 insufficiency.
  J Allergy Clin Immunol Volume: 149 Page(s): 736 - 746
  02/01/2022 Authors: Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari M-E; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patio V
• PI3K/ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
  Blood Volume: 139 Page(s): 523 - 537
  01/27/2022 Authors: Funk CR; Wang S; Chen KZ; Waller A; Sharma A; Edgar CL; Gupta VA; Chandrakasan S; Zoine JT; Fedanov A
• High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.
  Blood Adv Volume: 6 Page(s): 452 - 459
  01/25/2022 Authors: Dvila Saldaa BJ; John T; Bonifant C; Buchbinder D; Chandra S; Chandrakasan S; Chang W; Chen L; Elfassy HL; Geerlinks AV
• T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
  Blood Volume: 139 Page(s): 369 - 383
  01/20/2022 Authors: Kumar D; Prince C; Bennett CM; Briones M; Lucas L; Russell A; Patel K; Chonat S; Graciaa S; Edington H
• Real-World treatment Patterns and Outcomes in Patients with Hemophagocytic Lymphohistiocytosis (Hlh) and other Clinical Conditions Treated with Emapalumab: The Real-Hlh study Design
  Volume: 69 Page(s): S18 - S19
  01/01/2022 Authors: Oladapo A; Allen C; Leiding J; Chandrakasan S; Walkovich KJ; Oladapo A; Yee J; Pednekar P; Raza S; Jordan M
• Resolution of recurrent pediatric acute liver failure with liver transplantation in a patient with NBAS mutation.
  Pediatr Transplant Volume: 25 Page(s): e14084
  11/01/2021 Authors: Geem D; Jiang W; Rytting HB; Chandrakasan S; Salem A; Stevens JP; Karpen SJ; Magliocca JF; Romero R; Rodriguez DS
• THE ROLE OF T-CELL IMMUNE DYSREGULATION IN THE PATHOGENESIS OF INDETERMINATE ACUTE HEPATITIS
  Volume: 127 Page(s): S6 - S6
  11/01/2021 Authors: Nguyen T; Kumar D; Prince C; Romero R; Chandrakasan S
• TARGETING VASOACTIVE INTESTINAL PEPTIDE RECEPTOR SIGNALING IN PANCREATIC DUCTAL ADENOCARCINOMA FOR ENHANCED ANTI-TUMOR RESPONSE TO CHECKPOINT BLOCKADE
  Volume: 9 Page(s): A779 - A781
  11/01/2021 Authors: Ravindranathan S; Fnu TP; Li JM; Dhamsania R; Ware M; Zaidi M; Wang S; Zhu J; Cardenas M; Liu Y
• Correction to: T CellEpsteinBarr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in NonAsians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
  J Clin Immunol Volume: 41 Page(s): 1979
  11/01/2021 Authors: Shamriz O; Kumar D; Shim J; Briones M; Quarmyne M-O; Chonat S; Lucas L; Edington H; White MH; Mahajan A
• T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
  J Clin Immunol Volume: 41 Page(s): 1582 - 1596
  10/01/2021 Authors: Shamriz O; Kumar D; Shim J; Briones M; Quarmyne M-O; Chonat S; Lucas L; Edington H; White MH; Mahajan A
• Vasoactive Intestinal Peptide Receptor Signaling: A Novel and Targetable Immune Checkpoint Pathway in Pancreatic Cancer
  Volume: 50 Page(s): 1091 - 1092
  08/01/2021 Authors: Ravindranathan S; Tenzin P; Ware M; Zaidi M; Wang S; Dhamsania R; Zhu J; Liu Y; Liu Y; Gumber S
• Intravenous administration of anakinra in children with macrophage activation syndrome.
  Pediatr Rheumatol Online J Volume: 19 Page(s): 98
  06/29/2021 Authors: Phadke O; Rouster-Stevens K; Giannopoulos H; Chandrakasan S; Prahalad S
• Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
  Pediatr Rheumatol Online J Volume: 19 Page(s): 94
  06/21/2021 Authors: Villacis-Nunez DS; Rostad CA; Rouster-Stevens K; Khosroshahi A; Chandrakasan S; Prahalad S
• Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII.
  Mol Ther Methods Clin Dev Volume: 21 Page(s): 710 - 727
  06/11/2021 Authors: Russell AL; Prince C; Lundgren TS; Knight KA; Denning G; Alexander JS; Zoine JT; Spencer HT; Chandrakasan S; Doering CB
• PREDICTORS AND OUTCOMES OF IMMUNOGLOBULIN SUPPLEMENTATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
  Volume: 68 Page(s): S53 - S53
  06/01/2021 Authors: Edington H; DeGroote N; Miller T; Stevenson J; Chandrakasan S; Mertens A; Castellino S
• HSCT RESCUES MARROW FAILURE IN A PATIENT WITH LEUKEMIA AND PREVIOUSLY UNDIAGNOSED LIGASE IV SYNDROME
  Volume: 68 Page(s): S184 - S185
  06/01/2021 Authors: Fridlyand D; Chandrakasan S; Aljudi A; Aumann W; Westfall E; Kirwan B; Bryson E; Keller F; Arnold S; Hong A
• HSCT RESCUES MARROW FAILURE IN A PATIENT WITH LEUKEMIA AND PREVIOUSLY UNDIAGNOSED LIGASE IV SYNDROME
  Volume: 68 Page(s): S198 - S199
  06/01/2021 Authors: Fridlyand DM; Chandrakasan S; Aljudi A; Aumann W; Westfall E; Kirwan B; Bryson EW; Keller FG; Arnold SD; Hong AL
• Psychosocial insights of parents of pediatric primary immune deficient (PID) patients who had genetic testing
  Volume: 41 Page(s): S105 - S105
  04/01/2021 Authors: Singh S; Lichten L; Ali N; Gray C; Li H; Chandrakasan S
• Hematopoietic stem cell transplantation using non-genotoxic anti-CD117 immunotoxin conditioning corrects immune deficiencies and restores immune function in ataxia telangiectasia mice
  Volume: 41 Page(s): S134 - S134
  04/01/2021 Authors: Russell A; Prince C; Kumar D; Knight K; Rayaprolu S; Xiao H; Rangaraju S; Spencer HT; Doering C; Chandrakasan S
• Hematopoietic Stem Cell Transplant Outcomes in Adolescent and Young Adults with Immune Disorders
  Volume: 41 Page(s): S31 - S31
  04/01/2021 Authors: Bauchat A; Lucas L; Leavenworth D; Parikh S; Chandrakasan S
• Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies.
  Blood Volume: 137 Page(s): 349 - 363
  01/21/2021 Authors: Kuehn HS; Niemela JE; Stoddard J; Mannurita SC; Shahin T; Goel S; Hintermeyer M; Heredia RJ; Garofalo M; Lucas L
• Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation.
  J Clin Immunol Volume: 41 Page(s): 89 - 98
  01/01/2021 Authors: Chandra S; Chandrakasan S; Dvila Saldaa BJ; Bleesing JJ; Jordan MB; Kumar AR; Grimley MS; Krupski C; Davies SM; Khandelwal P
• Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.
  Lupus Volume: 30 Page(s): 109 - 117
  01/01/2021 Authors: Ogbu EA; Chandrakasan S; Rouster-Stevens K; Greenbaum LA; Sanz I; Gillespie SE; Marion C; Okeson K; Prahalad S
• Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients.
  J Pediatric Infect Dis Soc Volume: 9 Page(s): 716 - 737
  12/31/2020 Authors: Dulek DE; Fuhlbrigge RC; Tribble AC; Connelly JA; Loi MM; El Chebib H; Chandrakasan S; Otto WR; Diorio C; Keim G
• International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
  Blood Adv Volume: 4 Page(s): 6039 - 6050
  12/08/2020 Authors: van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M
• Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
  J Clin Immunol Volume: 40 Page(s): 1211 - 1213
  11/01/2020 Authors: Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E
• Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease.
  Autoimmunity Volume: 53 Page(s): 253 - 260
  08/01/2020 Authors: Hadley T; Gillespie S; Espinoza H; Prince J; Gronbaek H; Chandrakasan S; Kuguthasan S; Kolachala VL; Gupta NA
• Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019.
  Pediatr Rheumatol Online J Volume: 18 Page(s): 53
  07/15/2020 Authors: Canna SW; Schulert GS; de Jesus A; Pickering A; Brunner H; Gadina M; Levine S; Goldbach-Mansky R; Boutelle J; Sinha R
• Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia.
  Pediatrics Volume: 146
  07/01/2020 Authors: Patel PA; Chandrakasan S; Mickells GE; Yildirim I; Kao CM; Bennett CM
• Dealing with a critical national shortage-Approaches to triaging immune globulin supply in pediatric hematology and oncology.
  Pediatr Blood Cancer Volume: 67 Page(s): e28260
  07/01/2020 Authors: Edington HJ; Sutton KS; Bennett C; Chandrakasan S; Sterner-Allison J; Castellino SM
• Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
  Blood Volume: 135 Page(s): 2094 - 2105
  06/04/2020 Authors: Burroughs LM; Petrovic A; Brazauskas R; Liu X; Griffith LM; Ochs HD; Bleesing JJ; Edwards S; Dvorak CC; Chaudhury S
• Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by UNC13D Genetic Defects.
  Hum Gene Ther Volume: 31 Page(s): 626 - 638
  06/01/2020 Authors: Takushi SE; Paik NY; Fedanov A; Prince C; Doering CB; Spencer HT; Chandrakasan S
• Optimizing Munc13-4 Expression from Lentiviral Vector Transduced Human T Cells
  Volume: 28 Page(s): 172 - 172
  04/28/2020 Authors: Takushi S; Tran R; Fedanov A; Doering CB; Chandrakasan S; Spencer HT
• Reduced Toxicity Allogeneic Hct With A Busulfan, Fludarabine Regimen: A Promising Approach For Non-CGD Primary Immune Deficiencies Requiring Myeloablation?
  Volume: 40 Page(s): S151 - S151
  04/01/2020 Authors: Chandra S; Chandrakasan S; Saldana BD; Bleesing J; Jordan M; Kumar A; Grimley M; Krupski C; Davies S; Marsh R
• IKAROS Dimerization Defects Associated With Hematologic Cytopenias and Malignancies
  Volume: 40 Page(s): S37 - S38
  04/01/2020 Authors: Kuehn HS; Mannurita SC; Shahin T; Niemela J; Stoddard J; Hintermeyer M; Heredia RJ; Garofalo M; Lucas L; Tondo A
• Experience with a Reduced Toxicity Busulfan, Fludarabine Regimen in Children Undergoing Allogeneic HCT for Non-CGD Primary Immune Deficiencies Requiring Myeloablation
  Volume: 26 Page(s): S214 - S215
  03/01/2020 Authors: Chandra S; Chandrakasan S; Bleesing JJ; Jordan MB; Kumar A; Grimley MS; Krupski MC; Davies SM; Marsh R
• Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC)
  Volume: 26 Page(s): S18 - S19
  03/01/2020 Authors: Thakar MS; Logan B; Buckley RH; Haddad E; Dvorak CC; O'Reilly RJ; Kapoor N; Satter LF; Martinez C; Pai S-Y
• High Incidence of Mixed T Cell Chimerism with Reduced Toxicity Conditioning Regimens in Non-Malignant Diseases Are Not Associated with Adverse Outcomes
  Volume: 26 Page(s): S164 - S164
  03/01/2020 Authors: LeBlanc Z; Lucas L; Leavenworth D; Chandrakasan S
• Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.
  Blood Adv Volume: 4 Page(s): 477 - 481
  02/11/2020 Authors: Carden MA; Gaddh M; Hoskote A; Brown M; Merrill V; Stowell SR; Chandrakasan S; Antun A; Kudchadkar R; Kotanchiyev S
• Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.
  Front Immunol Volume: 11 Page(s): 239
  01/01/2020 Authors: Chan AY; Leiding JW; Liu X; Logan BR; Burroughs LM; Allenspach EJ; Skoda-Smith S; Uzel G; Notarangelo LD; Slatter M
• Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
  J Clin Immunol Volume: 39 Page(s): 653 - 667
  10/01/2019 Authors: Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E
• Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation.
  Blood Adv Volume: 3 Page(s): 2250 - 2263
  08/13/2019 Authors: Waller EK; Logan BR; Fei M; Lee SJ; Confer D; Howard A; Chandrakasan S; Anasetti C; Fernando SM; Giver CR
• Early Onset Granulomatous Colitis Associated with a Mutation in NCF4 Resolved with Hematopoietic Stem Cell Transplantation.
  J Pediatr Volume: 210 Page(s): 220 - 225
  07/01/2019 Authors: Wright M; Chandrakasan S; Okou DT; Yin H; Jurickova I; Denson LA; Kugathasan S
• HEMATOPOIETIC STEM CELL TRANSPLANTATION GENE THERAPY FOR HEMOPHILIA A USING NON-GENOTOXIC ANTI-CD117 IMMUNOTOXIN CONDITIONING
  Volume: 21 Page(s): S17 - S18
  05/01/2019 Authors: Russell AL; Prince C; Zoine J; Sheilds J; Lytle A; Spencer H; Chandrakasan S; Doering CB
• Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case-based review.
  Pediatr Blood Cancer Volume: 66 Page(s): e27619
  05/01/2019 Authors: Chandrakasan S; Chandra S; Davila Saldana BJ; Torgerson TR; Buchbinder D
• Non-Genotoxic Anti-CD117 Immunotoxin Conditioning Facilitates Hematopoietic Stem Cell Transplantation Gene Therapy for Hemophilia A
  Volume: 27 Page(s): 8 - 9
  04/22/2019 Authors: Russell A; Prince C; Zoine J; Shields J; Lytle A; Spencer HT; Chandrakasan S; Doering CB
• Developing Ligand-Based Chimeric Antigen Receptors to Target Leukemic and Bone Marrow Stem Cells
  Volume: 27 Page(s): 171 - 172
  04/22/2019 Authors: Zoine JT; Prince CZ; Shields JE; Russell AL; Doering CB; Chandrakasan S; Spencer HT
• Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease.
  J Allergy Clin Immunol Volume: 143 Page(s): 1482 - 1495
  04/01/2019 Authors: Dorjbal B; Stinson JR; Ma CA; Weinreich MA; Miraghazadeh B; Hartberger JM; Frey-Jakobs S; Weidinger S; Moebus L; Franke A
• HSCT Utilizing Related Carrier Donor for CD40 Ligand Deficiency
  Volume: 39 Page(s): S124 - S125
  02/01/2019 Authors: Chandrakasan S; Chandra S; Kobrynski L; Parikh SH
• Evaluation of Persistent Hypogammaglobulinemia Post-rituximab in Patients Undergoing HSCT for XLP-1 Reveals Preserved Ability of B-cells to Class-switch and Differentiate to Plasmablasts In-vitro
  Volume: 39 Page(s): S146 - S148
  02/01/2019 Authors: Chandrakasan S; Marsh RA; Chandra S; Patel K; Bleesing J
• Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders.
  Immunol Allergy Clin North Am Volume: 39 Page(s): 113 - 128
  02/01/2019 Authors: Shamriz O; Chandrakasan S
• Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.
  J Allergy Clin Immunol Pract Volume: 7 Page(s): 1970 - 1985.e4
  01/01/2019 Authors: Farmer JR; Foldvari Z; Ujhazi B; De Ravin SS; Chen K; Bleesing JJH; Schuetz C; Al-Herz W; Abraham RS; Joshi AY
• EPSTEIN-BARR VIRUS INFECTION OF T AND NK CELLS CAUSES A SEVERE AND UNUSUAL FORM OF HEMOPHAGOCYTIC LYMPHOHITICYTOSIS AMONG HISPANIC PATIENTS
  Volume: 66 Page(s): S42 - S42
  01/01/2019 Authors: Shamriz O; Bunting ST; Briones M; Chonat S; Quarmyne M-O; Chandrakasan S
• The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018).
  J Allergy Clin Immunol Volume: 143 Page(s): 405 - 407
  01/01/2019 Authors: Dvorak CC; Haddad E; Buckley RH; Cowan MJ; Logan B; Griffith LM; Kohn DB; Pai S-Y; Notarangelo L; Shearer W
• Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome.
  Clin Immunol Volume: 197 Page(s): 219 - 223
  12/01/2018 Authors: Shamriz O; Patel K; Marsh RA; Bleesing J; Joshi AY; Lucas L; Prince C; Pencheva BB; Kobrynski L; Chandrakasan S
• International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
  Blood Volume: 132 Page(s): 2115 - 2124
  11/15/2018 Authors: van Rhee F; Voorhees P; Dispenzieri A; Foss A; Srkalovic G; Ide M; Munshi N; Schey S; Streetly M; Pierson SK
• Severe Congenital Neutropenia associated with SRP54 mutation in 22q11.2 Deletion Syndrome: Hematopoietic Stem Cell Transplantation Results in Correction of Neutropenia with Adequate Immune Reconstitution.
  J Clin Immunol Volume: 38 Page(s): 546 - 549
  07/01/2018 Authors: Carden MA; Connelly JA; Weinzierl EP; Kobrynski LJ; Chandrakasan S
• Screening for Wiskott-Aldrich syndrome by flow cytometry.
  J Allergy Clin Immunol Volume: 142 Page(s): 333 - 335.e8
  07/01/2018 Authors: Chiang SCC; Vergamini SM; Husami A; Neumeier L; Quinn K; Ellerhorst T; Sheppard L; Gifford C; Buchbinder D; Joshi A
• Recent outcome of hematopoietic cell transplantation for Wiskott-Aldrich syndrome is excellent in all donor types: A Primary Immune Deficiency Treatment Consortium (PIDTC) Study
  Volume: 38 Page(s): 399 - 400
  04/01/2018 Authors: Pai S-Y; Brazauskas R; Bleesing J; Dvorak CC; Kletzel M; Petrovic A; Prockop SE; Quinones R; Goldman FD; Quigg TC
• Hematopoietic stem cell transplantation in patients with primary immune regulatory disorders: a Primary Immune Deficiency Treatment Consortium (PIDTC) and Inborn Errors Working Party (IEWP) Study
  Volume: 38 Page(s): 367 - 367
  04/01/2018 Authors: Leiding JW; Chan A; Allenspach E; Uzel G; Notarangelo L; Gennery A; Slatter M; Smith AR; Pai S-Y; Marsh R
• Hypomorphic CARD11 mutations associated with diverse immunologic phenotypes with or without atopic disease
  Volume: 38 Page(s): 371 - 371
  04/01/2018 Authors: Dorjbal B; Stinson JR; Ma CA; Weinreich MA; Miraghazadeh B; Hartberger J; Frey-Jacobs S; Limaye S; Nejentsev S; Leahy TR
• Resolution of CGD Related Colitis after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Granulomatous Disease-Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)
  Volume: 24 Page(s): S53 - S54
  03/01/2018 Authors: Leiding JW; Logan BR; Yin Z; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs L; Skoda-Smith S; Chandrakasan S
• Revisiting Type 1 Diabetes as a Comorbidity in Patients with Juvenile Idiopathic Arthritis.
  J Pediatr Volume: 192 Page(s): 6 - 7
  01/01/2018 Authors: Chandrakasan S; Prahalad S
• Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development.
  Biomark Res Volume: 6 Page(s): 13
  01/01/2018 Authors: Sanyi A; Jaye DL; Rosand CB; Box A; Shanmuganathan C; Waller EK
• Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201
  Volume: 130
  12/07/2017 Authors: Fernando SM; Logan BR; Fei M; Lee SJ; Confer D; Howard A; Chandrakasan S; Giver CR; Anasetti C; Waller EK
• Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.
  Blood Volume: 130 Page(s): 1456 - 1467
  09/21/2017 Authors: Miot C; Imai K; Imai C; Mancini AJ; Kucuk ZY; Kawai T; Nishikomori R; Ito E; Pellier I; Dupuis Girod S
• International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
  Blood Volume: 129 Page(s): 1646 - 1657
  03/23/2017 Authors: Fajgenbaum DC; Uldrick TS; Bagg A; Frank D; Wu D; Srkalovic G; Simpson D; Liu AY; Menke D; Chandrakasan S
• Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant.
  J Allergy Clin Immunol Volume: 139 Page(s): 1040 - 1043.e2
  03/01/2017 Authors: Chandrakasan S; Marsh RA; Uzel G; Holland SM; Shah KN; Bleesing J
• KIT blockade is sufficient for donor hematopoietic stem cell engraftment in Fanconi anemia mice.
  Volume: 129 Page(s): 1048 - 1052
  02/23/2017 Authors: Chandrakasan S; Jayavaradhan R; Ernst J; Shrestha A; Loberg A; Dexheimer P; Jordan M; Pang Q; Aronow B; Malik P
• POOR IMMUNE RECONSTITUTION FOLLOWING MATCHED SIBLING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR X-LINKED LYMPHOPROLIFERATIVE DISORDER (XLP): SHOULD WE RECONSIDER MATCHED CARRIER SIBLINGS AS HSCT DONORS IN X-LINKED IMMUNE DEFICIENCY?
  Volume: 37 Page(s): 255 - 256
  02/01/2017 Authors: Mallapaty A; Bleesing JJ; Chandrakasan S
• X-Linked Lymphoproliferative Syndrome (XLP1) Diagnosed after Rituximab
  Volume: 139 Page(s): AB21 - AB21
  02/01/2017 Authors: Mallapaty A; Chandrakasan S; Patel K
• Nonclassic Inflammatory Bowel Disease in Young Infants: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, and Other Disorders.
  Pediatr Clin North Am Volume: 64 Page(s): 139 - 160
  02/01/2017 Authors: Chandrakasan S; Venkateswaran S; Kugathasan S
• CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation
  Volume: 128
  12/02/2016 Authors: Sano H; Hilinski J; Applegate K; Camacho-Gonzalez A; Chandrakasan S; Chiang K-Y; Haight A; Krishnamurti L; Stenger E; Qayed M
• DIAGNOSIS OF SEVERE COMBINED IMMUNODEFICIENCY (SCID) IN A PATIENT WITH AUTOIMMUNITY
  Volume: 117 Page(s): S86 - S86
  11/01/2016 Authors: Mallapaty A; Hofmekler T; Patel K; Chandrakasan S
• Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.
  Br J Haematol Volume: 175 Page(s): 744 - 747
  11/01/2016 Authors: Chonat S; Chandrakasan S; Kalinyak KA; Ingala D; Gruppo R; Kalfa TA
• KIT Blockade Is Sufficient to Sustain Donor Hematopoietic Stem Cell Engraftment in Fanconi Anemia Mice
  Volume: 126
  12/03/2015 Authors: Chandrakasan S; Jayavaradhan R; John E; Shrestha A; Dexheimer P; Jordan MB; Pang Q; Aronow BJ; Malik P
• Pathogenesis of Hemophagocytic Lymphohistiocytosis.
  Hematol Oncol Clin North Am Volume: 29 Page(s): 895 - 902
  10/01/2015 Authors: Filipovich AH; Chandrakasan S
• The use of a Berlin Heart EXCOR LVAD in a child receiving chemotherapy for Castleman's disease.
  Pediatr Transplant Volume: 19 Page(s): E15 - E18
  02/01/2015 Authors: Thomas TO; Chandrakasan S; O'Brien M; Jefferies JL; Ryan TD; Wilmot I; Baker ML; Madueme PC; Morales D; Lorts A
• ADOLESCENTS AND YOUNG ADULTS WITH HLH WHO UNDERGO ALLOGENEIC HCT ARE AT INCREASED RISK OF MORTALITY COMPARED TO YOUNGER PATIENTS
  PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): 2130 - 2131
  11/01/2014 Authors: Chandrakasan S; Marsh RA; Bellman D; Grimley M; Bleesing J; Jordan M; Filipovich A
• SYNERGISTIC DEFECTS OF DIFFERENT MOLECULES IN THE CYTOTOXIC PATHWAY LEAD TO CLINICAL FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
  PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): 2142 - 2143
  11/01/2014 Authors: Zhang K; Chandrakasan S; Husami A; Kissell D; Filipovich AH
• Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
  Biol Blood Marrow Transplant Volume: 20 Page(s): 1641 - 1645
  10/01/2014 Authors: Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
• Hematopoietic Cell Transplant for Autoimmune Lymphoproliferative Syndrome: A Single Center Experience
  Volume: 34 Page(s): S181 - S181
  10/01/2014 Authors: Chandrakasan S; Kuerbitz S; Bleesing J
• Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis.
  Blood Volume: 124 Page(s): 1331 - 1334
  08/21/2014 Authors: Zhang K; Chandrakasan S; Chapman H; Valencia CA; Husami A; Kissell D; Johnson JA; Filipovich AH
• ECULIZUMAB TREATMENT OF THROMBOTIC MICROANGIOPATHY (TMA) IN SICKLE CELL DISEASE
  PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S38 - S38
  05/01/2014 Authors: Chonat S; Chandrakasan S; Kalinyak K; Ingala D; Gruppo R; Kalfa T
• Gene therapy for hemoglobinopathies: the state of the field and the future.
  Hematol Oncol Clin North Am Volume: 28 Page(s): 199 - 216
  04/01/2014 Authors: Chandrakasan S; Malik P
• Iron-refractory microcytic anemia as the presenting feature of unicentric Castleman disease in children.
  J Pediatr Volume: 164 Page(s): 928 - 930
  04/01/2014 Authors: Chandrakasan S; Bakeer N; Mo JQ; Cost C; Quinn CT
• Clinical and genetic profile of children with periodic fever syndromes from a single medical center in South East Michigan.
  J Clin Immunol Volume: 34 Page(s): 104 - 113
  01/01/2014 Authors: Chandrakasan S; Chiwane S; Adams M; Fathalla BM
• An overview of hemoglobinopathies and the interpretation of newborn screening results.
  Pediatr Ann Volume: 42 Page(s): 502 - 508
  12/01/2013 Authors: Chandrakasan S; Kamat D
• Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment.
  J Pediatr Volume: 163 Page(s): 1253 - 1259
  11/01/2013 Authors: Chandrakasan S; Filipovich AH
• AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IN MONOZYGOTIC TWINS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS LIKE INITIAL PRESENTATION
  PEDIATRIC BLOOD & CANCER Volume: 60 Page(s): S44 - S45
  06/01/2013 Authors: Chandrakasan S; Filipovich A; Bleesing J
• CASTLEMAN'S DISEASE PRESENTING AS IRON-REFRACTORY MICROCYTIC ANEMIA - A REPORT OF TWO CASES
  PEDIATRIC BLOOD & CANCER Volume: 60 Page(s): S30 - S30
  06/01/2013 Authors: Chandrakasan S; Bakeer N; Mo JQ; Cost C; Quinn C
• Granulomatosis with polyangiitis presenting as Henoch-Schnlein purpura in children.
  J Clin Rheumatol Volume: 19 Page(s): 199 - 202
  06/01/2013 Authors: Bui T; Chandrakasan S; Poulik J; Fathalla BM
• HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS LIKE PRESENTATION OF AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IN MONOZYGOTIC TWINS
  JOURNAL OF CLINICAL IMMUNOLOGY Volume: 33 Page(s): 688 - 689
  04/01/2013 Authors: Chandrakasan S; Bleesing JJ
• CLINICAL SPECTRUM AND OUTCOME OF HEMATOPOIETIC CELL TRANSPLANT FOR PATIENTS WITH NEMO DEFECT: A SINGLE CENTER EXPERIENCE
  JOURNAL OF CLINICAL IMMUNOLOGY Volume: 33 Page(s): 677 - 677
  04/01/2013 Authors: Chandrakasan S; Bleesing JJ; Marsh R; Filipovich AH
• DOCK-8 DEFICIENCY- A CASE OF COMBINED IMMUNODEFICIENCY, EOSINOPHILIA AND ATOPY WITHOUT ELEVATED SERUM IgE
  JOURNAL OF CLINICAL IMMUNOLOGY Volume: 33 Page(s): 694 - 694
  04/01/2013 Authors: Chandrakasan S; Su H; Kumar AR
• Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience
  Volume: 19 Page(s): S284 - S284
  02/01/2013 Authors: Chandrakasan S; Marsh RA; Bellman D; Grimley M; Bleesing J; Jordan M; Davies S; Filipovich A
• Hematopoietic Cell Transplant for Patients With NEMO Defect: A Single Center Experience
  Volume: 19 Page(s): S244 - S244
  02/01/2013 Authors: Chandrakasan S; Bleesing J; Bellman D; Marsh RA; Davies S; Filipovich A
• Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.
  Rheumatol Int Volume: 32 Page(s): 881 - 886
  04/01/2012 Authors: Singh S; Chandrakasan S; Ahluwalia J; Suri D; Rawat A; Ahmed N; Das R; Sachdeva MUS; Varma N
• Risk factors and management of deep venous thrombosis in children following post-surgical hypopituitarism in craniopharyngioma.
  Pediatr Blood Cancer Volume: 57 Page(s): 175 - 177
  07/15/2011 Authors: Chandrakasan S; Sood S; Ham S; Moltz K; Frey MJ; Rajpurkar M
• Malignant fibrous histiocytoma two years after autologous stem cell transplant for Hodgkin lymphoma: evidence for genomic instability.
  Pediatr Blood Cancer Volume: 56 Page(s): 1143 - 1145
  07/01/2011 Authors: Chandrakasan S; Ye CJ; Chitlur M; Mohamed AN; Rabah R; Konski A; Heng HHQ; Savaan S
• Wiskott-Aldrich syndrome presenting with early onset recurrent acute hemorrhagic edema and hyperostosis.
  Pediatr Blood Cancer Volume: 56 Page(s): 1130 - 1132
  07/01/2011 Authors: Chandrakasan S; Singh S; Dogra S; Delaunay J; Proust A; Minz RW
• MACROPHAGE ACTIVATION SYNDROME IN CHILDREN FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION-REPORT OF TWO CASES
  PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 692 - 692
  04/01/2011 Authors: Chandrakasan S; Chu R; Yaddanapudi R; Savasan S
• MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS: CLINICAL EXPERIENCE FROM NORTH INDIA
  PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 692 - 692
  04/01/2011 Authors: Singh S; Chandrakasan S; Ahluwalia J; Suri D; Das R; Ahmed N; Varma N
• AUTOSOMAL RECESSIVE CHRONIC GRANULOMATOUS DISEASE (CGD) PRESENTING WITH LIVER ABSCESSES
  ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY Volume: 103 Page(s): A81 - A82
  11/01/2009 Authors: Reddy S; Chandrakasan S; Butt A; Secord E
• Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis.
  Rheumatol Int Volume: 29 Page(s): 565 - 567
  03/01/2009 Authors: Chandrakasan S; Singh S; Ratho RK; Kumar S; Mishra B